Article
Oncology
Shady I. Tantawy, Aloke Sarkar, Stefan Hubner, Zhi Tan, William G. Wierda, Abdelraouf Eldeib, Shuxing Zhang, Steven Kornblau, Varsha Gandhi
Summary: This study aims to investigate the mechanism of MCL-1i-induced Mcl-1 protein stability. Both in vivo and in vitro experiments demonstrate that MCL-1i-induced Mcl-1 protein stability is mainly associated with defective Mcl-1 ubiquitination and concurrent apoptosis induction. Additionally, MCL-1i also enhances Mcl-1Thr163 phosphorylation via ERK pathway, contributing to Mcl-1 stability.
CLINICAL CANCER RESEARCH
(2023)
Article
Biochemistry & Molecular Biology
Marlen Michalski, Magdalena Bauer, Franziska Walz, Deniz Tuemen, Philipp Heumann, Petra Stoeckert, Manuela Gunckel, Claudia Kunst, Arne Kandulski, Stephan Schmid, Martina Mueller, Karsten Guelow
Summary: Despite recent advances in therapy, hepatocellular carcinoma (HCC) prognosis remains poor. This study presents the potential of combining BH3-mimetics as a new treatment option for HCC. BH3-mimetics inhibit anti-apoptotic proteins, triggering the intrinsic apoptosis pathway. The combination of two BH3-mimetic inhibitors showed enhanced efficacy in inducing the apoptosis pathway in HCC cell lines, suggesting the potential of this approach as a new therapeutic option for HCC.
Article
Cell Biology
Ming Li, Feng Gao, Xiaoying Li, Yu Gan, Shuangze Han, Xinfang Yu, Haidan Liu, Wei Li
Summary: The E3 ligase TRAF4 is closely related to radioresistance in oral squamous cell carcinoma (OSCC) by stabilizing MCL-1 through Akt signaling. Targeting TRAF4 may be a promising strategy to overcome radioresistance in OSCC.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Tuo Deng, Zihao He, Xiaolu Duan, Di Gu, Chao Cai, Wenqi Wu, Yongda Liu, Guohua Zeng
Summary: STAM1 expression is lower in ccRCC compared with normal renal tissues, and is associated with shorter overall survival in patients. In vitro experiments show that STAM1 inhibits cell viability, invasion, and migration in ccRCC cell lines. Further research is needed to understand the mechanisms of STAM1 in modulating ccRCC.
FRONTIERS IN ONCOLOGY
(2021)
Article
Cell Biology
Tong-bing Wang, Mei Geng, Hua Jin, Ai-guo Tang, Hao Sun, Liu-zheng Zhou, Bin-hai Chen, Gang Shen, Qiang Sun
Summary: The inhibitor PF-429242 targeting S1P showed potent inhibition of RCC cell growth both in vitro and in vivo, inducing apoptosis in the cells. Silencing or knockout of S1P had similar inhibitory effects, while overexpression of SREBP1 and S1P enhanced RCC cell proliferation and migration.
CELL DEATH & DISEASE
(2021)
Article
Oncology
Yi Wang, Ye Tian, Shouyong Liu, Zengjun Wang, Qianwei Xing
Summary: This study revealed that AXL plays prognostic and immunological roles in ccRCC, and identified LncRNA/RBP/AXL mRNA axes as potential mechanisms. The nomogram including AXL expression and clinicopathological factors was established and GSEA results showed association between elevated AXL expression and various signaling pathways. AXL was also significantly linked to tumor microenvironment, immune cells, immune infiltration, immune checkpoint molecules, and tumor mutational burden (TMB).
CANCER CELL INTERNATIONAL
(2021)
Article
Cell Biology
Gang Wang, Fangfang Qu, Jincai Zhou, Bingye Zhu, Yulong Gao
Summary: This study evaluated the prognostic value of THBS3 in clear cell renal cell carcinoma (ccRCC) and identified its relationship with the immune system. The expression of THBS3 was found to be negatively correlated with patient survival, and several signal pathways and LncRNA/RBP/THBS3 mRNA networks associated with THBS3 were identified.
Review
Biochemistry & Molecular Biology
Pooja Mittal, Sujata Singh, Rajesh Sinha, Anju Shrivastava, Archana Singh, Indrakant Kumar Singh
Summary: MCL-1 plays a crucial role in cancer cells and its overexpression is associated with drug resistance. Advancements in selective MCL-1 inhibitors offer new therapeutic strategies for cancer treatment.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2021)
Article
Cell Biology
Ze Gao, Junxiu Chen, Yiran Tao, Qiong Wang, Shirong Peng, Shunli Yu, Jianwen Zeng, Kaiwen Li, Zhongqiu Xie, Hai Huang
Summary: By analyzing the TME and gene mutations of ccRCC patients, a prognostic immune score model was established to identify suitable patients for immunotherapy and select more appropriate drug combinations.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Wengang Jian, Wei Xue, Tengda Wang, Yongchun Yu, Licheng Cai, Yuyang Meng, Zhinan Xia, Cheng Zhang
Summary: RBM4 has been identified as a tumor suppressor gene in clear cell renal cell carcinoma (ccRCC), inhibiting tumor progression by promoting the activity of the p53 signaling pathway through enhancing the stability of p53 mRNA. This suggests that RBM4 may serve as a potential target for the treatment of ccRCC patients.
MOLECULAR CARCINOGENESIS
(2023)
Article
Cell Biology
Fan Zhang, Junyu Lin, Dechao Feng, Jiayu Liang, Yiping Lu, Zhihong Liu, Xianding Wang
Summary: This study explored the correlation between cuprotosis and clear cell renal cell carcinoma (ccRCC) and developed a cuprotosis-related signature to predict the prognosis of patients with ccRCC. The signature risk score was significantly associated with tumor stage, histological grade, and immune cell infiltrates in ccRCC.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Article
Cell Biology
Jiehui Di, Hui Wang, Zhongjun Zhao, Guang Zhao, Xiaobing Qin, Zhengxiang Han, Yong Liu
Summary: The study found that CPEB4 acts as a tumor suppressor gene in RCC by inhibiting tumor growth through increasing p21 mRNA stability and inducing G1 cell cycle arrest. This suggests that CPEB4 may be a promising predictive biomarker for prognosis in patients with RCC.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Pathology
Tam Pham, Chisato Ohe, Takashi Yoshida, Takahiro Nakamoto, Hidefumi Kinoshita, Koji Tsuta
Summary: This study aimed to evaluate the association of HIF2 alpha protein and HIF2A mRNA expression with clinicopathological factors and histomorphological features related to vasculature and inflammation in clear cell renal cell carcinoma (ccRCC). The results showed that HIF2 alpha expression was associated with tumor characteristics, vascular status, and inflammation, and was also related to patient prognosis.
PATHOLOGY RESEARCH AND PRACTICE
(2023)
Article
Biotechnology & Applied Microbiology
Zuhu Yu, Chong Lu, Bin Lu, Hong Gao, Rongfang Liang, Wuxing Xiang
Summary: This study identified necroptosis-related microRNAs (miRNAs) associated with the prognosis of clear cell renal cell carcinoma (ccRCC), and developed a prognostic signature to predict overall survival in ccRCC patients. The targeted genes of these miRNAs were predicted using miRNA databases, and their functional and pathway associations with ccRCC prognosis were investigated. The differential expression of the three miRNAs in the signature was validated in ccRCC tissues.
Article
Multidisciplinary Sciences
Kangsan Kim, Qinbo Zhou, Alana Christie, Christina Stevens, Yuanqing Ma, Oreoluwa Onabolu, Suneetha Chintalapati, Tiffani Mckenzie, Vanina Toffessi Tcheuyap, Layton Woolford, He Zhang, Nirmish Singla, Pravat Kumar Parida, Mauricio Marquez-Palencia, Ivan Pedrosa, Vitaly Margulis, Arthur Sagalowsky, Zhiqun Xie, Tao Wang, Steffen Durinck, Zora Modrusan, Somasekar Seshagiri, Payal Kapur, James Brugarolas, Srinivas Malladi
Summary: In this study, the authors explore the determinants of vascular invasion and metastasis in RCC patients with tumor thrombi (TT). They found that tumor thrombi associated with metastases are characterized by higher grade, mTOR activation, and a particular immune contexture. TT grade is a better predictor of metastasis than overall tumor grade.
NATURE COMMUNICATIONS
(2021)
Article
Oncology
Alberto Sada Japp, M. Alper Kursunel, Sarah Meier, Julia N. Malzer, Xiangdong Li, Nafis A. Rahman, Waltraut Jekabsons, Hans Krause, Ahmed Magheli, Christian Klopf, Andreas Thiel, Marco Frentsch
CANCER IMMUNOLOGY IMMUNOTHERAPY
(2015)
Article
Biochemistry & Molecular Biology
Manuel Luedeke, Antje E. Rinckleb, Liesel M. FitzGerald, Milan S. Geybels, Johanna Schleutker, Rosalind A. Eeles, Manuel R. Teixeira, Lisa Cannon-Albright, Elaine A. Ostrander, Steffen Weikert, Kathleen Herkommer, Tiina Wahlfors, Tapio Visakorpi, Katri A. Leinonen, Teuvo L. J. Tammela, Colin S. Cooper, Zsofia Kote-Jarai, Sandra Edwards, Chee L. Goh, Frank McCarthy, Chris Parker, Penny Flohr, Paula Paulo, Carmen Jeronimo, Rui Henrique, Hans Krause, Sven Wach, Verena Lieb, Tilman T. Rau, Walther Vogel, Rainer Kuefer, Matthias D. Hofer, Sven Perner, Mark A. Rubin, Archana M. Agarwal, Doug F. Easton, Ali Amin Al Olama, Sara Benlloch, Josef Hoegel, Janet L. Stanford, Christiane Maier
HUMAN MOLECULAR GENETICS
(2016)
Article
Urology & Nephrology
Frank vom Dorp, Stephan Tschirdewahn, Christian Niedworok, Henning Reis, Hans Krause, Carsten Kempkensteffen, Jonas Busch, Gero Kramer, Shahrokh F. Shariat, Peter Nyirady, Herbert Ruebben, Tibor Szarvas
JOURNAL OF UROLOGY
(2016)
Article
Chemistry, Analytical
Andrey Bogomolov, Valeria Belikova, Urszula J. Zabarylo, Olga Bibikova, Iskander Usenov, Tatiana Sakharova, Hans Krause, Olaf Minet, Elena Feliksberger, Viacheslav Artyushenko
Article
Urology & Nephrology
Frank Christoph, Frank Konig, Steffen Lebentrau, Burkhard Jandrig, Hans Krause, Romy Strenziok, Martin Schostak
WORLD JOURNAL OF UROLOGY
(2018)
Article
Oncology
Anica Hoegner, Hans Krause, Burkhard Jandrig, Mumtaz Kasim, Tom Florian Fuller, Martin Schostak, Andreas Erbersdobler, Andreas Patzak, Ergin Kilic
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
(2018)
Article
Cell Biology
Gareth Catchpole, Alexander Platzer, Cornelia Weikert, Carsten Kempkensteffen, Manfred Johannsen, Hans Krause, Klaus Jung, Kurt Miller, Lothar Willmitzer, Joachim Selbig, Steffen Weikert
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2011)
Article
Oncology
Angelka Toelle, Hans Krause, Kurt Miller, Klaus Jung, Carsten Stephan
Article
Urology & Nephrology
Imad Alkamal, Odiljon Ikromov, Angelika Toelle, Tom Florian Fuller, Ahmed Magheli, Kurt Miller, Hans Krause, Carsten Kempkensteffen
UROLOGIA INTERNATIONALIS
(2015)
Article
Urology & Nephrology
Stefan Hinz, Ahmed Magheli, Steffen Weikert, Wolfgang Schulze, Hans Krause, Mark Schrader, Kurt Miller, Carsten Kempkensteffen
WORLD JOURNAL OF UROLOGY
(2010)
Article
Urology & Nephrology
Romy Strenziok, Stefan Hinz, Christian Wolf, Tim Conrad, Hans Krause, Kurt Miller, Mark Schrader
WORLD JOURNAL OF UROLOGY
(2010)
Article
Urology & Nephrology
Florian Jentzmik, Hans Krause, Ute Reichelt, Andres Jan Schrader, Mark Schrader, Daniel Baumunk, Hannes Cash, Kurt Miller, Martin Schostak
WORLD JOURNAL OF UROLOGY
(2012)
Article
Urology & Nephrology
Daniel Baumunk, Uta Reichelt, Jannis Hildebrandt, Hans Krause, Jan Ebbing, Hannes Cash, Kurt Miller, Martin Schostak, Steffen Weikert
WORLD JOURNAL OF UROLOGY
(2013)
Review
Virology
Burkhard Jandrig, Hans Krause, Wolfgang Zimmermann, Emilija Vasiliunaite, Alma Gedvilaite, Rainer G. Ulrich
Summary: Hamster polyomavirus, also known as HaPyV, is an important tumor model for Syrian hamsters due to its association with skin tumors and lymphomas. The virus belongs to the Alphapolyomavirus genus and has a typical genome organization with early and late transcriptional regions. The major capsid protein VP1 of HaPyV has potential applications in generating virus-like particles for research purposes.
Article
Physiology
Christin Boldt, Tom Roeschel, Nina Himmerkus, Allein Plain, Markus Bleich, Robert Labes, Maximilian Blum, Hans Krause, Ahmed Magheli, Torsten Giesecke, Kerim Mutig, Michael Rothe, Steven M. Weldon, Duska Dragun, Wolf-Hagen Schunck, Sebastian Bachmann, Alexander Paliege
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
(2016)